Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Bank OZK

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Finance analyst
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Following recent evaluations by analysts, Bank OZK (NASDAQ: OZK) has garnered a range of ratings in the past quarter, spanning from optimistic to pessimistic outlooks. Here are the key takeaways:

Total Ratings: Analysts have issued 1 bullish, 1 somewhat bullish, 1 neutral, and 2 somewhat bearish ratings, with no outright bearish ratings in the most recent period.

Price Targets: The average 12-month price target for Bank OZK stands at $50.0, with a high estimate of $58.00 and a low estimate of $39.00. This represents a 6.38% uptick from the previous average target of $47.00.

Recent Analyst Actions:
– Ben Gerlinger of Citigroup downgraded the rating to Buy, setting a price target of $57.00.
– Jared Shaw from Wells Fargo also downgraded the rating to Underweight, with a price target of $39.00.
– Michael Rose at Raymond James upgraded the rating to Outperform, with a price target of $58.00.
– Jennifer Demba of Truist Securities raised the rating to Hold, with a price target of $55.00.

These analyst actions and ratings offer valuable insights into how Bank OZK is perceived in the current market landscape, reflecting responses to evolving market conditions and company performance.

OZK Stock Shows Stability and Positive Performance on March 13, 2024

On March 13, 2024, OZK stock had a relatively stable performance, trading in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $43.10, which was a $0.21 increase from the previous market close, representing a 0.49% rise. Despite a slight dip in after-hours trading, OZK’s overall performance on March 13, 2024, was relatively positive, with the stock showing resilience and maintaining its position above its 200-day simple moving average. Investors will likely continue to monitor OZK’s stock performance in the coming days to assess any further fluctuations and potential opportunities for investment.

OZK Stock Shows Strong Financial Performance with Significant Revenue and EPS Growth in 2024

On March 13, 2024, OZK stock showed promising performances with significant increases in total revenue and earnings per share compared to the previous year. According to data from CNN Money, OZK reported a total revenue of $2.25 billion for the past year, which marks a 63.03% increase from the previous year. In the fourth quarter alone, the total revenue was $642.52 million, showing an 8.67% increase from the previous quarter.

Net income for OZK also showed positive growth, with a net income of $690.78 million for the past year, representing a 22.45% increase from the previous year. However, the net income for the fourth quarter remained flat at $175.13 million compared to the previous quarter.

Earnings per share (EPS) for OZK also saw a significant increase, with an EPS of $5.87 for the past year, marking a 29.5% increase from the previous year. In the fourth quarter, the EPS remained flat at $1.50 compared to the previous quarter.

Overall, OZK stock demonstrated strong financial performance with impressive growth in total revenue and EPS compared to the previous year. Investors may view these positive indicators as a sign of the company’s continued success and potential for future growth.

Tags: OZK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Paramount Global Sells Stake in Viacom18 to Reliance Industries

Renewable energy

Title OPAL Fuels Reports Quarterly Financial Results with Mixed Performance

Finance_ Investing in stocks

Robinhood Markets Inc Reports Impressive Growth Metrics and Stock Price Surge

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com